Navigation Links
DiversityInc Names Lilly a Top Company for Diversity
Date:4/25/2012

INDIANAPOLIS, April 25, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has been named to the 2012 DiversityInc Top 50 Companies for Diversity list. Lilly ranked 29th, an increase from its 2011 rating of 39.

DiversityInc's "Top 50 Companies for Diversity" is known as the leading assessment of diversity management globally. To make the list, participating companies must have more than 1,000 employees and demonstrate strength in key diversity areas: CEO commitment, human capital, corporate and organizational communications, and supplier diversity ­­– while also showing year-to-year progress in diversity initiatives.

"We believe diversity is critical to innovation. Our inclusion on the DiversityInc list is a great honor and validation of our efforts to create an environment where innovation can flourish," said Shaun Hawkins, chief diversity officer. "Embracing diversity is at the core of our long-held value of respect for people. It is the lens through which we understand and respond to the unique needs of the millions of individuals who depend on our medicines.

"Our diversity commitment extends through the full spectrum of our business, including our supply chain, clinical trial strategy and marketing. We also work to ensure that diversity is embedded in our global practices, policies and training, and in recent years, we have increased our leaders' accountability for developing diverse talent," Hawkins said.

Methodology
A total of 587 companies participated in the 2012 DiversityInc Top 50 competition, up 11 percent from last year. The evaluation for placement consists of more than 300 empirical questions across four areas: CEO commitment, human capital, corporate and organizational communications, and supplier diversity.

The results are determined by statistical analysis. It is an independent editorial process and there is no fee to enter the competition and no requirement to conduct business with DiversityInc.

There has been significant movement on the list this year:

  • Twenty companies moved up in rank; 24 moved down; six kept the same ranking
  • Three companies moved on to the list from the 25 Noteworthy Companies list last year
  • Two companies came back to the list after falling off last year
  • Two companies made the list for the first time, one of which was a first-time participant

The top 50 companies, selected from among 587 submissions, were announced April 24 in New York. To see the full list, visit http://diversityinc.com/the-diversityinc-top-50-companies-for-diversity-2012/.

To learn more about diversity at Lilly, visit www.lilly.com/about/diversity/Pages/diversity.aspx.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations.

Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com. C-LLY

(Logo:  http://photos.prnewswire.com/prnh/20031219/LLYLOGO)


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Avion Pharmaceuticals, LLC Names Michael Sullivan as new VP, Sales and Marketing
2. Quest Diagnostics Names Steve Rusckowski as President and CEO
3. Omeros Names Dr. Patrick Gray as Scientific Fellow
4. CRF Institute Names Sigma-Aldrich Top Employer Europe 2012
5. Wound Management Technologies Names Robert Lutz, Jr. as New CEO; Buys Back North American Distribution Rights for CellerateRX® Powder
6. Aptuit LLC Names Stuart E. Needleman as President and Chief Operating Officer
7. ORTHOCON® Names David J. Hart Vice President of Business Operations
8. Zeus Healthcare Names Larry Havelis as CEO
9. RoundTable Healthcare Partners Names Kent J. Davies CEO of Newly Formed Platform Development Corporation
10. InterMune Names Jonathan A. Leff, M.D., as Executive Vice President of Research and Development
11. SalesCongo Names Ken Kaisen CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, Inc. ... providing the Urology, Uro/Gyn and Gynecology markets with innovative ... first quarter ended March 31, 2017 after the market ... The Company will host a conference call and webcast ... Tuesday, May 2, 2017 at 4:30 p.m. Eastern Time ...
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., developer ... series to be presented at the 2017 National Kidney ... today and continues through April 22. Physicians will present ... used to assess risk for acute kidney injury (AKI) ... failure (ADHF). Elevated levels of TIMP-2 ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ... modern procedure that achieves results in a fraction of the time as traditional ... NV, with Significance Dental Specialists, now offers this revolutionary treatment with or without ...
(Date:4/25/2017)... ... ... Back Pain Centers of America (BPC), which connects people searching ... area, announces the launch of a new and proprietary customer relationship management (CRM) system ... physicians to help them with back or neck pain and helps to match them ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, ... to its patient care management module. Using this new feature, sleep physicians can ... been initiated on continuous positive airway pressure (CPAP), oral, or other forms of ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the ... CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet in ...
Breaking Medicine News(10 mins):